Ascendent Capital Partners II, GP, L.P. - Net Worth and Insider Trading
Ascendent Capital Partners II, GP, L.P. Net Worth
The estimated net worth of Ascendent Capital Partners II, GP, L.P. is at least $604 Million dollars as of 2024-09-28. Ascendent Capital Partners II, GP, L.P. is the 2201 Interest of corporation controlled by you of SciClone Pharmaceuticals (Holdings) Ltd and owns about 32,259,037 shares of SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) stock worth over $604 Million. Details can be seen in Ascendent Capital Partners II, GP, L.P.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ascendent Capital Partners II, GP, L.P. has not made any transactions after 2023-12-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ascendent Capital Partners II, GP, L.P.
Ascendent Capital Partners II, GP, L.P. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ascendent Capital Partners II, GP, L.P. owns 1 companies in total, including SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) .
Insider Ownership Summary of Ascendent Capital Partners II, GP, L.P.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HKSE:06600 | SciClone Pharmaceuticals (Holdings) Ltd | 2023-12-07 | 2201 Interest of corporation controlled by you |
Ascendent Capital Partners II, GP, L.P. Latest Holdings Summary
Ascendent Capital Partners II, GP, L.P. currently owns a total of 1 stock. Ascendent Capital Partners II, GP, L.P. owns 32,259,037 shares of SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) as of December 7, 2023, with a value of $604 Million.
Latest Holdings of Ascendent Capital Partners II, GP, L.P.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HKSE:06600 | SciClone Pharmaceuticals (Holdings) Ltd | 2023-12-07 | 32,259,037 | 18.72 | 603,889,173 |
Holding Weightings of Ascendent Capital Partners II, GP, L.P.
Ascendent Capital Partners II, GP, L.P. Form 4 Trading Tracker
According to the SEC Form 4 filings, Ascendent Capital Partners II, GP, L.P. has made a total of 4 transactions in SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in SciClone Pharmaceuticals (Holdings) Ltd is the sale of 29,600,000 shares on December 7, 2023, which brought Ascendent Capital Partners II, GP, L.P. around $0.
Insider Trading History of Ascendent Capital Partners II, GP, L.P.
- 1
Ascendent Capital Partners II, GP, L.P. Trading Performance
Ascendent Capital Partners II, GP, L.P. Ownership Network
Ascendent Capital Partners II, GP, L.P. Owned Company Details
What does SciClone Pharmaceuticals (Holdings) Ltd do?
Who are the key executives at SciClone Pharmaceuticals (Holdings) Ltd?
Ascendent Capital Partners II, GP, L.P. is the 2201 Interest of corporation controlled by you of SciClone Pharmaceuticals (Holdings) Ltd. Other key executives at SciClone Pharmaceuticals (Holdings) Ltd include 2201 Interest of corporation controlled by you UBS Group AG , 2101 Beneficial owner Zhao Hong , and Gl Capital Management Gp Limited .
SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) Insider Trades Summary
Over the past 18 months, Ascendent Capital Partners II, GP, L.P. made 2 insider transaction in SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) with a net sale of 0. Other recent insider transactions involving SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) include a net purchase of 354,500 shares made by UBS Group AG , a net sale of 0 shares made by Zhao Hong , and a net sale of 0 shares made by Meng Liang .
In summary, during the past 3 months, insiders sold 0 shares of SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) were sold and 354,500 shares were bought by its insiders, resulting in a net purchase of 354,500 shares.
SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600)'s detailed insider trading history can be found in Insider Trading Tracker table.
SciClone Pharmaceuticals (Holdings) Ltd Insider Transactions
Ascendent Capital Partners II, GP, L.P. Mailing Address
Above is the net worth, insider trading, and ownership report for Ascendent Capital Partners II, GP, L.P.. Currently GuruFocus does not have mailing address information for Ascendent Capital Partners II, GP, L.P..